{
  "meta": {
    "title": "Liver",
    "url": "https://brainandscalpel.vercel.app/liver-61bd3467.html",
    "scrapedAt": "2025-11-30T08:51:28.927Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum Creatinine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Total Bilirubin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">INR</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum Albumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male with a history of cirrhosis is being evaluated for liver transplantation. The MELD score is calculated to assess his prognosis. Which of the following is NOT included in the calculation of the MELD score?</span></p>",
      "unique_key": "DT1296344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>MELD Score</strong></p>\r\n<ul>\r\n<li>Model for End-Stage Liver Disease (MELD) score</li>\r\n<li>The MELD score is calculated based on <strong>(CBI)</strong>\r\n<ul>\r\n<li><strong>Serum creatinine</strong></li>\r\n<li><strong>Total bilirubin</strong></li>\r\n<li><strong>INR</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>To assess liver disease severity and prioritize liver transplantation candidates.</p>\r\n<ul>\r\n<li>The MELD score was devised to predict the <strong>short-term prognosis following trans jugular intrahepatic portosystemic stent shunt (TIPSS) </strong>but has been adopted to prioritize patients on liver transplant waiting lists.</li>\r\n<li><strong>MELD scores correlate with operative mortality: </strong>1% increase for each MELD point up to 20 and a further 2% for each point above 20, with rates considerably higher following emergency presentation.</li>\r\n</ul>\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Serum Creatinine: Included in the MELD score. Reflects kidney function, which is important in cirrhotic patients.</p>\r\n<p>Option B. Total Bilirubin: Included in the MELD score. Indicates liver function and bile excretion.</p>\r\n<p>Option C. INR: Included in the MELD score. Measures the liver's ability to produce clotting factors.</p>\r\n<p>Option D. Serum Albumin: Not included in the MELD score. Albumin is often used in other scoring systems like the Child-Pugh score but not in MELD.</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li><strong>MELD score components: creatinine, bilirubin, INR.</strong></li>\r\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Portal vein thrombosis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Budd-Chiari syndrome</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic artery aneurysm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old female presents with abdominal pain, hepatomegaly, and ascites. Doppler ultrasound shows absent flow in the hepatic veins. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1296347",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Budd-Chiari Syndrome</strong></p>\r\n<ul>\r\n<li>Impaired hepatic venous outflow from hepatic veins to IVC.</li>\r\n<li>Key Features: <strong>Triad of abdominal pain, ascites, hepatomegaly.</strong></li>\r\n<li>Common in young women with hypercoagulable conditions.</li>\r\n<li>Complications:\r\n<ul>\r\n<li>Liver congestion</li>\r\n<li>portal hypertension</li>\r\n<li>ascites, varices</li>\r\n<li>cirrhosis</li>\r\n<li>liver failure.</li>\r\n</ul>\r\n</li>\r\n<li>Diagnosis: Doppler ultrasonography, CT scan, and hematological studies.\r\n<ul>\r\n<li>CT scan demonstrates a large, congested liver or cirrhosis with <strong>gross enlargement of the caudate lobe </strong>resulting from preservation and hypertrophy of the segment due to direct venous drainage to the IVC.</li>\r\n</ul>\r\n</li>\r\n<li>Treatment:\r\n<ul>\r\n<li>Liver transplantation for fulminant failure or cirrhosis;</li>\r\n<li><strong>TIPSS, portocaval shunt, or IVC stenting if liver function is normal.</strong></li>\r\n<li>Lifelong anticoagulation is often required.</li>\r\n</ul>\r\n</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115d8118eaf-242d-4604-bd91-47b9139590a0.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Portal vein thrombosis: Incorrect. <strong>Portal vein thrombosis can cause portal hypertension and ascites,</strong> but it does not involve the hepatic veins, which are occluded in Budd-Chiari syndrome.</p>\r\n<p>Option B. Budd-Chiari syndrome: Correct. Budd-Chiari syndrome is caused by <strong>obstruction of hepatic venous outflow, leading to hepatomegaly, ascites, and abdominal pain.</strong> Doppler ultrasound typically shows absent or reduced flow in the hepatic veins.</p>\r\n<p>Option C. Cirrhosis: Incorrect. <strong>Cirrhosis </strong>presents with similar symptoms but usually shows <strong>diffuse liver fibrosis</strong> rather than specific venous obstruction.</p>\r\n<p>Option D. Hepatic artery aneurysm: Incorrect. <strong>A hepatic artery aneurysm</strong> typically presents with a different clinical picture, such as <strong>upper abdominal pain or rupture,</strong> and does not cause hepatic venous obstruction.</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li><strong>Triad of abdominal pain, ascites, hepatomegaly with gross enlargement of the caudate lobe- Budd chiari syndrome</strong></li>\r\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B infection</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis C infection</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallstones</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with chronic fatigue, pruritus, and jaundice. His liver function tests reveal a cholestatic liver enzyme pattern, and MRCP shows stricturing of the bile ducts. Which of the following is most commonly associated with primary sclerosing cholangitis?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011527997fbf-4eff-4de0-9eb3-19c3b5e29105.jpg\"></span></p>",
      "unique_key": "DT1296351",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Primary Sclerosing Cholangitis (PSC)</strong></p>\r\n<ul>\r\n<li><strong>Chronic cholestatic liver disease </strong>linked to <strong>ulcerative colitis.</strong></li>\r\n<li>Causes <strong>inflammation, fibrosis, and stricturing of bile ducts, </strong>leading to a <strong>'beaded'</strong> appearance on cholangiography.</li>\r\n<li>Affects mostly <strong>young men </strong>in their 30s.</li>\r\n<li>Diagnosed by cholangiography; liver biopsy may be needed.</li>\r\n<li>Increased risk of <strong>cholangiocarcinoma </strong>and gallbladder cancer.</li>\r\n<li>No specific treatment; liver transplantation is definitive for advanced disease.</li>\r\n<li>Temporary <strong>relief by biliary stenting,</strong> but risk of cholangitis.</li>\r\n<li><strong>In patients with PSC and ulcerative colitis, the condition usually progresses even following colectomy.</strong></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501158f7ac1db-5de0-425f-aef7-712e827bbb2c.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Hepatitis B infection: Incorrect. Hepatitis B is not commonly linked with PSC.</p>\r\n<p>Option B. Ulcerative colitis: Correct. PSC is strongly associated with ulcerative colitis.</p>\r\n<p>Option C. Hepatitis C infection: Incorrect. Hepatitis C is not linked with PSC.</p>\r\n<p>Option D. Gallstones: Incorrect. Gallstones are not associated with PSC.</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li>Liver transplantation is the definitive treatment for advanced disease or cholangiocarcinoma risk.</li>\r\n<li>Biliary stenting can provide temporary relief for obstructive jaundice, but with risk of cholangitis.</li>\r\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal Nodular Hyperplasia (FNH)</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic Adenoma</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular Carcinoma (HCC)</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female presents with abdominal discomfort. She has a history of long-term oral contraceptive use. An abdominal MRI reveals a solitary liver lesion with a central scar and no capsule. What is the most likely diagnosis?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115f5f29cbf-c835-4dd5-960f-a3bae3334dc9.jpg\"></span></p>",
      "unique_key": "DT1296358",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296358,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Focal Nodular Hyperplasia (FNH)</strong></p>\r\n<ul>\r\n<li><strong>Benign </strong>liver condition of unknown cause.</li>\r\n<li>Typically affects <strong>middle-aged women.</strong></li>\r\n<li>No association with underlying liver disease.</li>\r\n<li>Characterized by <strong>focal overgrowth of functioning liver tissue supported by fibrous stroma.</strong></li>\r\n<li>Diagnosed through ultrasonography, showing a <strong>solid tumor mass.</strong></li>\r\n<li>Contrast CT or MRI may reveal a <strong>central scar and hypervascular lesion.</strong></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501156e227b1a-2f50-4ff2-9fa0-369e2d2a4983.jpg\">\r\n<ul>\r\n<li>FNH contains <strong>hepatocytes and Kupfer cells.</strong></li>\r\n<li>MRI with liver-specific contrast can differentiate FNH from metastatic cancer.</li>\r\n<li><strong>No malignant potential</strong></li>\r\n<li><strong>No treatment </strong>or follow-up is required once diagnosed.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501150688a74d-1f18-42ef-b528-fc4cd0cd5eb9.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Focal Nodular Hyperplasia (FNH): Correct. Characterized by a <strong>central scar,</strong> commonly seen on imaging, and benign with no malignant potential. No capsule present.</p>\r\n<p>Option B. Hepatic Adenoma: Incorrect. Typically associated with <strong>oral contraceptive use,</strong> but lacks a central scar. Higher risk of rupture and malignant transformation.</p>\r\n<p>Option C. Hepatocellular Carcinoma (HCC): Incorrect. <strong>Shows arterial enhancement and rapid washout, often in cirrhotic patients,</strong> unlike FNH.</p>\r\n<p>D. Hemangioma: Incorrect. Shows <strong>peripheral nodular enhancement with centripetal filling&nbsp;</strong>on delayed phases, not resembling FNH.</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li>FNH has a characteristic central scar.</li>\r\n<li>Hepatic adenoma has malignant potential.</li>\r\n</ul>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade III</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade IV</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade V</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade VI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male patient sustains a penetrating trauma to the abdomen. On exploratory laparotomy, a grade IV liver laceration involving the inferior vena cava (IVC) is discovered. According to the AAST liver injury scale, what grade corresponds to a liver injury involving the major hepatic veins or retrohepatic vena cava?</span></p>",
      "unique_key": "DT1296363",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Explanation of Options:</p>\r\n<p>Option A. Grade III: Incorrect. Grade III liver injuries involve lacerations greater than 3 cm but do not involve major vascular structures.</p>\r\n<p>Option B. Grade IV: Incorrect. Grade IV involves major lacerations or parenchymal disruption, but without injury to the major hepatic veins or vena cava.</p>\r\n<p>Option C. Grade V: Correct. Grade V injuries involve parenchymal disruption of more than 75% of the liver lobe or major injuries to the hepatic veins or retrohepatic vena cava.</p>\r\n<p>Option D. Grade VI: Incorrect. Grade VI represents hepatic avulsion, which is a near-complete or complete separation of the liver from its vascular attachments.</p>\r\n<p><strong>Liver Injury Grading</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115cd65d542-e3dc-42dd-afa9-7ee54d63a942.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011539fd115a-4160-4327-9b9c-64252d60544f.jpg\">\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li><strong>Grade V liver injuries </strong>include those involving major vascular structures like the <strong>inferior vena cava or hepatic veins.</strong></li>\r\n<li>These injuries carry a <strong>high risk of hemorrhage </strong>and require immediate surgical intervention.</li>\r\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcified cyst wall</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Daughter cysts forming within the mother cyst</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Detached endocyst floating within the cyst</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Perforation of the cyst into the biliary tree</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male presents with right upper quadrant pain and is suspected to have a liver hydatid cyst. On imaging, a \"water lily sign\" is observed. What does this sign represent in hydatid disease?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011522060c5c-f3a0-4d46-8a3a-f604e69d6b16.jpg\"></span></p>",
      "unique_key": "DT1296369",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296369,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Hydatid Disease</strong></p>\r\n<ul>\r\n<li>Caused by infection with the <strong>Echinococcus granulosus</strong></li>\r\n<li>The liver is the most common site, but other organs may also be involved.</li>\r\n</ul>\r\n<p><strong>Waterlily Sign:</strong></p>\r\n<ul>\r\n<li>Seen on imaging in hydatid cyst (echinococcosis).</li>\r\n</ul>\r\n<ul>\r\n<li>Caused by the detachment of the endocyst (inner membrane), which floats in the cyst's fluid, creating a layered appearance similar to waterlily petals.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501150496d23f-4bd2-44b5-8b9d-d4e97a535e0d.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501158314cad5-05a2-494a-9605-82d776d51bdc.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011560a6fd8b-665b-4fb1-8e81-caaa6b9c0c55.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Calcified cyst wall: Incorrect<strong><strong>. </strong>Calcification of the cyst wall</strong> may occur in chronic hydatid disease, but it is not associated with the \"waterlily sign.\"</p>\r\n<p>Option B. Daughter cysts forming within the mother cyst: Incorrect. While daughter cysts are characteristic of hydatid disease, they are not responsible for the \"waterlily sign.\"</p>\r\n<p>Option C. Detached endocyst floating within the cyst: Correct. The \"waterlily sign\" refers to the<strong> appearance of the detached endocyst floating within the fluid of the cyst, resembling a waterlily.</strong> This occurs due to the rupture of the hydatid cyst's inner membrane.</p>\r\n<p>Option D. Perforation of the cyst into the biliary tree: Incorrect. Cyst perforation into the biliary tree is a complication but does not produce the \"waterlily sign.\"</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li><strong>The waterlily sign is a classic radiological finding in hydatid disease representing the floating detached endocyst.</strong></li>\r\n<li><strong>It is an important diagnostic clue in cases of hepatic hydatid cyst.</strong></li>\r\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopic sclerotherapy</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopic band ligation</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Balloon tamponade</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous octreotide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male with a history of cirrhosis presents with hematemesis. He is diagnosed with esophageal varices. Which of the following is the preferred method for managing acute bleeding from esophageal varices?</span></p>",
      "unique_key": "DT1296373",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296373,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Variceal bleeding management </strong></p>\r\n<ol>\r\n<li>Endoscopic Band Ligation (EBL):</li>\r\n</ol>\r\n<ul>\r\n<li>First-line treatment for acute esophageal variceal bleeding.</li>\r\n<li>Involves the placement of <strong>rubber bands around varices to induce thrombosis and fibrosis</strong>, effectively stopping the bleeding.</li>\r\n<li>Fewer complications (e.g., strictures, ulcers) and lower rebleeding rates than sclerotherapy.</li>\r\n</ul>\r\n<ol start=\"2\">\r\n<li>Endoscopic Sclerotherapy:</li>\r\n</ol>\r\n<ul>\r\n<li>Historically used to manage variceal bleeding, it involves injecting a <strong>sclerosing agent into the varices.</strong></li>\r\n<li>Associated with a higher risk of complications such as <strong>esophageal ulcers, strictures, and rebleeding.</strong></li>\r\n</ul>\r\n<ol start=\"3\">\r\n<li>Adjunctive Therapies:</li>\r\n</ol>\r\n<ul>\r\n<li>Octreotide: A somatostatin analog that helps <strong>reduce portal hypertension</strong>and is used alongside endoscopic treatment.</li>\r\n<li>Balloon Tamponade (Sengstaken-Blakemore tube): Used in cases of <strong>massive or uncontrolled bleeding as a temporary measure.</strong></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501159fad6e5d-3f1b-4603-9942-7fee4862eebd.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Endoscopic sclerotherapy: Incorrect. While sclerotherapy has been used historically, it is associated with a higher risk of complications such as <strong>esophageal ulcers and strictures compared to band ligation.</strong></p>\r\n<p>Option B. Endoscopic band ligation: Correct<strong>. Endoscopic band ligation (EBL) is the preferred treatment for acute esophageal variceal bleeding.</strong> It has fewer complications and a lower rebleeding rate compared to sclerotherapy.</p>\r\n<p>Option C. Balloon tamponade: Incorrect. Balloon tamponade (e.g., <strong>Sengstaken-Blakemore tube</strong>) is used as a temporary measure in massive bleeding when endoscopic techniques fail or are unavailable, but it is not the first-line treatment.</p>\r\n<p>Option D. Intravenous octreotide: Incorrect. While <strong>octreotide is used to reduce portal pressure and control bleeding, it is usually administered in combination with definitive treatments such as EBL, not as a standalone therapy.</strong></p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li>Endoscopic band ligation is the preferred first-line treatment for acute esophageal variceal bleeding, as it is more effective and has fewer complications compared to sclerotherapy.</li>\r\n<li>Sclerotherapy is rarely used today due to the availability of safer and more effective alternatives like EBL.</li>\r\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemangioma</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal nodular hyperplasia (FNH)</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma (HCC)</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver metastasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male with a history of chronic hepatitis presents with abdominal pain. A contrast-enhanced CT scan reveals a hypervascular liver lesion in the arterial phase and washout in the venous phase. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1296376",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296376,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Liver Lesions on CT</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115297083e1-af35-4474-a8ef-7b1bcb783076.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Hemangioma: Incorrect. Hemangiomas typically show a <strong>peripheral, nodular enhancement in the arterial phase, with progressive centripetal filling in delayed phases on contrast-enhanced CT scans.</strong></p>\r\n<p>Option B. Focal nodular hyperplasia (FNH): Incorrect. <strong>FNH shows a homogeneous, hyper vascular lesion in the arterial phase with a central scar that enhances in the delayed phase.</strong> It usually lacks washout in the venous phase, which differentiates it from HCC.</p>\r\n<p>Option C. Hepatocellular carcinoma (HCC): Correct. HCC often shows arterial phase hyperenhancement with rapid washout in the venous or delayed phase, which is typical of malignant tumors. This is a characteristic finding on contrast-enhanced CT in patients with cirrhosis or chronic liver disease.</p>\r\n<p>Option D. Liver metastasis: Incorrect. <strong>Liver metastases are typically hypovascular and show rim enhancement in the arterial phase with delayed washout,</strong> but they do not demonstrate the characteristic washout pattern seen in HCC.</p>\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li>HCC typically demonstrates arterial phase hyperenhancement followed by rapid washout in the venous phase, which distinguishes it from benign lesions like hemangioma or FNH.</li>\r\n<li>Hemangiomas show progressive filling from the periphery to the center in delayed phases.</li>\r\n</ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">From the gallbladder fossa to the inferior vena cava</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">From the falciform ligament to the right hepatic vein</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Along the left hepatic duct to the portal vein</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Along the right hepatic artery to the caudate lobe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male is undergoing a liver resection for hepatocellular carcinoma. During the operation, the surgeon identifies Cantlie's line as a landmark for liver division. Which of the following best describes the anatomical location of Cantlie's line?</span></p>",
      "unique_key": "DT1296389",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296389,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Segmental Anatomy of the Liver</strong></p>\r\n<ul>\r\n<li>The liver is divided into right and left functional units along <strong>Cantlie's line (between the gallbladder fossa and middle hepatic vein).</strong></li>\r\n<li><strong>Couinaud Segments:</strong> The liver is divided into eight segments, each considered a functional unit.</li>\r\n<li>Supply and Drainage: Each segment is supplied by its <strong>own branch of the hepatic artery, portal vein, and bile duct,</strong> and drained by a hepatic vein tributary.</li>\r\n<li><strong>Right Liver (Segments V-VIII): </strong>Supplied by the right hepatic artery, right portal vein, and drained by the right hepatic duct.</li>\r\n<li><strong>Left Liver (Segments I-IV): </strong>Supplied by the left hepatic artery, left portal vein, and drained by the left hepatic duct.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115b8aee288-6abd-45ea-b263-d2b6307f537a.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011558f394e5-911f-4343-96fc-d4a33caa751d.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. From the gallbladder fossa to the inferior vena cava: Correct. Cantlie's line is an imaginary line that divides the liver into right and left functional lobes. It runs from the gallbladder fossa anteriorly to the inferior vena cava posteriorly.</p>\r\n<p>Option B. From the falciform ligament to the right hepatic vein: Incorrect.</p>\r\n<p>Option C. Along the left hepatic duct to the portal vein: Incorrect.</p>\r\n<p>Option D. Along the right hepatic artery to the caudate lobe: Incorrect.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum bilirubin > 50 &micro;mol/L</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">INR > 2.0</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum bilirubin > 300 &micro;mol/L</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Age > 60 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with a history of alcohol abuse is admitted with acute liver failure. His condition is rapidly deteriorating. Which of the following is included in the King's College Criteria for determining the need for liver transplantation in patients with non-paracetamol-related acute liver failure?</span></p>",
      "unique_key": "DT1296392",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296392,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>King's College Criteria for Liver Transplantation</strong></p>\r\n<ul>\r\n<li><strong>acute liver failure</strong>\r\n<ul>\r\n<li><strong>evidence of coagulation abnormality, usually an international normalised ratio above 1.5,and any degree of mental alteration (encephalopathy) in a patient without pre-existing liver disease and with an illness of less than 26 weeks' duration.</strong></li>\r\n</ul>\r\n</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501150324f86b-8b70-496c-a864-ba5c84919bd0.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Serum bilirubin &gt; 50 &micro;mol/L: Incorrect.</p>\r\n<p>Option B. INR &gt; 2.0: Incorrect. INR is a part of the criteria, but the threshold is INR &gt; 6.5 for paracetamol-related cases.</p>\r\n<p>Option C. Serum bilirubin &gt; 300 &micro;mol/L: Correct. A serum bilirubin &gt; 300 &micro;mol/L is one of the criteria indicating poor prognosis and need for transplantation.</p>\r\n<p>Option D. Age &gt; 60 years: Incorrect. Age itself is not a direct criterion in King's College Criteria, but age &lt;10 or &gt;40 can affect prognosis in specific cases.</p>\r\n<p><strong>Key Points: </strong>Paracetamol-associated liver failure: Based on factors like INR, creatinine, encephalopathy, and jaundice onset.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">7 (Class B)</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">9 (Class B)</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">10 (Class C)</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">12 (Class C)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old female with cirrhosis presents with worsening ascites, encephalopathy, and jaundice. Her lab results show the following:<br>Bilirubin: 3.5 mg/dL<br>Albumin: 2.5 g/dL<br>INR: 1.8<br>Moderate ascites on clinical exam<br>Hepatic encephalopathy: Grade 2<br>What is her Child-Pugh score and the corresponding class?</span></p>",
      "unique_key": "DT1296396",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296396,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>To calculate the Child-Pugh score, assign points based on the following parameters:</p>\r\n<ul>\r\n<li>Total Child-Pugh Score:</li>\r\n</ul>\r\n<ul>\r\n<li>Bilirubin (3 points) + Albumin (3 points) + INR (2 points) + Ascites (2 points) + Encephalopathy (2 points) = 10 points</li>\r\n<li>This corresponds to Child-Pugh Class C.</li>\r\n</ul>\r\n<p><strong>Child-Pugh Score </strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011539351d89-f2a0-49cd-bf91-b575bf90fdaa.jpg\">\r\n<p>Classification:</p>\r\n<ul>\r\n<li>Class A (5-6 points): Mild disease</li>\r\n<li>Class B (7-9 points): Moderate disease</li>\r\n<li>Class C (10-15 points): Severe disease</li>\r\n<li>Overall surgical mortality rates are increased by 10% in CTP-A disease, 30% in CTP-B and 75-80% in CTP-C</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501159555d612-6225-45ad-bf53-341e8eae3e32.jpg\">\r\n<p><strong>Key Points: </strong>Bilirubin, albumin, INR, ascites, and encephalopathy are the five clinical and laboratory parameters used.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Refractory ascites</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Variceal bleeding not controlled with endoscopic therapy</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic encephalopathy</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Budd Chiari syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male with cirrhosis and recurrent variceal bleeding is referred for Transjugular Intrahepatic Portosystemic Shunt (TIPSS) placement. Which of the following is NOT an indication for TIPSS?</span></p>",
      "unique_key": "DT1296403",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296403,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS)</strong></p>\r\n<ul>\r\n<li>Indication: Used in refractory portal hypertension, particularly when pharmacological and <strong>endoscopic therapies fail to control variceal bleeding.</strong></li>\r\n<li>Procedure: TIPSS is inserted via the internal jugular vein, creating a stent between the portal and systemic veins to reduce portal pressure.</li>\r\n<li>Complications:\r\n<ul>\r\n<li>Include liver capsule perforation,</li>\r\n<li>TIPSS occlusion</li>\r\n<li><strong>post-TIPSS encephalopathy.</strong></li>\r\n</ul>\r\n</li>\r\n<li>Contraindication: Portal vein occlusion.</li>\r\n<li>Long-Term Issues: <strong>Stenosis of the stent can occur in up to 50% of patients within one year.</strong></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501156d5069b1-91da-4b93-9fd6-4e34df2afbbf.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Refractory ascites: Incorrect. <strong>TIPSS is indicated for refractory ascites</strong> when diuretic therapy fails.</p>\r\n<p>Option B. Variceal bleeding not controlled with endoscopic therapy: Incorrect. TIPSS is often used to manage variceal bleeding that does not respond to endoscopic or medical therapy.</p>\r\n<p>Option C. Hepatic encephalopathy: Correct. <strong>TIPSS can worsen hepatic encephalopathy,</strong> and it is not an indication for the procedure. In fact, it is a relative contraindication.</p>\r\n<p>Option D. Budd Chiari syndrome: Incorrect. TIPSS can be used to relieve portal hypertension in patients with Budd Chiari syndrome.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Every 1-2 hours</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Every 4-6 hours</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Every 48 hours</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Every 24 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with cirrhosis is admitted to the ICU due to variceal bleeding. A Sengstaken Blakemore tube is placed to temporarily control the bleeding. What is the recommended timing for deflation of the esophageal balloon to prevent complications?</span></p>",
      "unique_key": "DT1296410",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296410,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Balloon Tamponade and Self-Expanding Stents</strong></p>\r\n<ul>\r\n<li>Balloon Tamponade is a temporary measure for massive or refractory variceal bleeding and is used as a <strong>'bridge' </strong>to more definitive treatments.</li>\r\n<li><strong>Sengstaken-Blakemore Tube </strong>and <strong>Minnesota Tube</strong> are commonly used for tamponade. They provide hemostasis by inflating a gastric balloon in the fundus and esophageal balloon at <strong>60 mmHg</strong></li>\r\n<li>Management Protocols are crucial to avoid complications such as <strong>esophageal pressure necrosis. </strong>deflate balloon at every 6-12 hours .</li>\r\n<li>Self-expanding metal stents have recently been used for the emergency treatment of esophageal varices, offering results similar to balloon tamponade except for intragastric bleeding.</li>\r\n<li>This approach allows temporary control of variceal bleeding while preparing for more definitive interventions like TIPSS.</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115e425c80c-a4d2-4080-8c7c-0ff0e75cf126.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501150134235a-aa8f-4ca3-bcda-c9212d0d1794.jpg\">\r\n<p>Explanation of Options:</p>\r\n<p>Option A. Every 1-2 hours: Incorrect. This interval is too frequent and may result in insufficient compression to control bleeding.</p>\r\n<p>Option B. Every 4-6 hours: Correct. It is recommended to deflate the esophageal balloon every 4-6 hours to prevent mucosal ischemia and necrosis, which could lead to complications.</p>\r\n<p>Option C. Every 48 hours: Incorrect. Delaying deflation beyond 6 hours may increase the risk of mucosal damage and complications.</p>\r\n<p>Option D. Every 24 hours: Incorrect. Waiting this long increases the risk of ischemic damage to the esophagus.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Occurs in younger patients</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with elevated alpha fetoprotein (AFP)</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonly seen in cirrhotic livers</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Poor prognosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30 year old female with no history of liver disease presents with a mass in the liver. Imaging suggests fibrolamellar carcinoma. Which of the following features differentiates fibrolamellar carcinoma from hepatocellular carcinoma (HCC)?</span></p>",
      "unique_key": "DT1296413",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296413,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Fibrolamellar Variant Hepatocellular Carcinoma (HCC)</strong></p>\r\n<ul>\r\n<li>Typically affects <strong>younger </strong>patients <strong>without a history of cirrhosis.</strong></li>\r\n<li>Tumour Characteristics: Well-demarcated and encapsulated with a <strong>central fibrotic area, resembling FNH</strong>(Focal Nodular Hyperplasia).</li>\r\n<li>Histology: Large polygonal tumor cells arranged in fibrous stroma forming lamellar structures.</li>\r\n<li>Markers: <strong>Does not produce AFP; associated with elevated neurotensin levels.</strong></li>\r\n<li><strong>Prognosis:</strong> Generally <strong>better than conventional HCC,</strong> with long-term survival expected in 50% to 75% after resection.</li>\r\n<li>Management: <strong>Surgical resection</strong></li>\r\n</ul>\r\n<p>Explanation:</p>\r\n<p>Option A. Occurs in younger patients: Correct. Fibrolamellar carcinoma typically occurs <strong>in younger patients</strong> without underlying liver disease, unlike HCC.</p>\r\n<p>Option B. Associated with elevated alpha fetoprotein (AFP): Incorrect. <strong>AFP is commonly elevated in HCC but not in fibrolamellar carcinoma.</strong></p>\r\n<p>Option C. Commonly seen in cirrhotic livers: Incorrect. <strong>Fibrolamellar carcinoma occurs in noncirrhotic livers,</strong> while HCC is strongly associated with cirrhosis.</p>\r\n<p>Option D. Poor prognosis: Incorrect. Fibrolamellar carcinoma generally has a better prognosis compared to HCC.</p>\r\n<p><strong>Key points:</strong></p>\r\n<ul>\r\n<li>Fibrolamellar carcinoma occurs in younger patients without cirrhosis, whereas HCC is associated with older patients and cirrhosis. AFP levels are typically elevated in HCC but not in fibrolamellar carcinoma.</li>\r\n</ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate surgical resection</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Empirical antibiotic therapy and aspiration for culture</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydatid cyst management protocol</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation with serial imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old diabetic male presents with fever, malaise, and right upper quadrant pain. A CT scan reveals a multiloculated cystic mass with an air-fluid level in the liver. What is the most appropriate initial management for this patient?<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011509e2264c-9555-4ad4-9435-81549ddd80af.jpg\"></span></p>",
      "unique_key": "DT1296420",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296420,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Liver Abscess</strong></p>\r\n<ul>\r\n<li>Common Causative Agents: Polymicrobial, typically <strong>Klebsiella, Escherichia coli,</strong> and <strong>Streptococcus </strong>milleri group.</li>\r\n<li>Risk Factors: <strong>Elderly, diabetic, and immunosuppressed individuals.</strong></li>\r\n<li>Diagnosis: Multiloculated cystic mass on CT or ultrasound, confirmed by aspiration.</li>\r\n<li>Management: Includes aspiration for microbiological diagnosis and broad-spectrum antibiotics (e.g., metronidazole, third-generation cephalosporins).</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501153f439cf4-8149-4466-a9ec-167195bca524.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011556568d8e-a90b-4dce-9a9e-fdf4760487ad.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Immediate surgical resection: Incorrect. <strong>Surgery is rarely the first-line treatment</strong> unless there is <strong>failure of drainage or the abscess is unresponsive to other treatments.</strong></p>\r\n<p>Option B. Empirical antibiotic therapy and aspiration for culture: Correct. Initial management of a liver abscess includes identifying the source, <strong>aspirating for microbiology, and administering antibiotics.</strong></p>\r\n<p>Option C. Hydatid cyst management protocol: Incorrect. Hydatid cysts require specific antiparasitic treatment, not empiric antibiotics, and are managed differently.</p>\r\n<p>Option D. Observation with serial imaging: Incorrect. Active management is needed in the form of <strong>antibiotics and aspiration;</strong> observation alone is not appropriate for liver abscesses.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Early Stage (BCLC A)</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Intermediate Stage (BCLC B)</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Advanced Stage (BCLC C)</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">End Stage (BCLC D)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old male with cirrhosis and a single 4 cm hepatocellular carcinoma lesion is being assessed for treatment. According to the BCLC staging system, what stage is this patient likely to be in?</span></p>",
      "unique_key": "DT1296423",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296423,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>BCLC Staging for HCC</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115367b008b-118b-428a-b1b4-8d969c86dc79.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Early Stage (BCLC A): Correct<strong>. Early Stage HCC</strong> is characterised by a <strong>single lesion &le; 5 cm or up to three lesions &le; 3 cm, with preserved liver function (Child Pugh A or B).</strong></p>\r\n<p>Option B. Intermediate Stage (BCLC B): Incorrect. Intermediate <strong>Stage includes multiple tumors and preserved liver function but no vascular invasion or extrahepatic spread.</strong></p>\r\n<p>Option C. Advanced Stage (BCLC C): Incorrect. <strong>Advanced Stage includes vascular invasion or extrahepatic spread.</strong></p>\r\n<p>Option D. End Stage (BCLC D): Incorrect. <strong>End Stage involves severe liver dysfunction (Child Pugh C)</strong> or poor performance status.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Kocher manoeuvre</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Pringle manoeuvre</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Halsted manoeuvre</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Thompson manoeuvre</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a liver resection, the surgeon temporarily occludes the hepatoduodenal ligament to control bleeding. This manoeuvre is known as:</span></p>",
      "unique_key": "DT1296428",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Pringle Maneuver</strong></p>\r\n<ul>\r\n<li>The Pringle manoeuvre is a surgical technique used to control bleeding from the liver by <strong>temporarily occluding the blood flow through the hepatic artery and portal vein.</strong> This method is commonly used during liver surgery or trauma to minimise blood loss.</li>\r\n<li>Procedure: A soft clamp or finger compression is applied to the <strong>hepatoduodenal ligament (which contains the hepatic artery and portal vein) </strong>to temporarily occlude blood flow to the liver.</li>\r\n<li>Duration: The maneuver can usually be applied for up to <strong>20 minutes </strong>without causing significant liver damage, followed by short periods of reperfusion.</li>\r\n<li>Limitations: Prolonged use can lead to <strong>liver ischemia, and it is not effective in controlling bleeding from the hepatic veins or inferior vena cava.</strong></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115d1e15ff9-767c-4aa6-b4d5-405b63cf2d71.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Kocher manoeuvre: Incorrect. This involves <strong>mobilisation of the duodenum</strong>, not liver vascular control.</p>\r\n<p>Option B. Pringle manoeuvre: Correct. The Pringle manoeuvre involves <strong>clamping the hepatoduodenal ligament to control bleeding from the liver by occluding the portal vein and hepatic artery.</strong></p>\r\n<p>Option C. Halsted manoeuvre: Incorrect. This is not related to liver surgery.</p>\r\n<p>Option D. Thompson manoeuvre: Incorrect. This manoeuvre does not apply to liver resection.</p>\r\n<p><strong>Key point:</strong></p>\r\n<ul>\r\n<li>The Pringle manoeuvre is used during liver surgery to control bleeding by clamping the hepatoduodenal ligament, which contains the hepatic artery and portal vein.</li>\r\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver transplantation</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical resection</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiofrequency ablation</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Sorafenib</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60 year old patient with hepatocellular carcinoma (HCC) presents with a single tumour measuring 4 cm, preserved liver function, and no portal hypertension. According to the BCLC staging system, what is the most appropriate treatment?</span></p>",
      "unique_key": "DT1296432",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296432,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>BCLC Staging for HCC</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250115079a5508-112b-4bcf-bef6-a484ef2d6056.jpg\">\r\n<p>Explanation:</p>\r\n<p>Option A. Liver transplantation: Incorrect. <strong>Liver transplantation</strong> is more appropriate for patients with <strong>decompensated cirrhosis and multiple small tumors.</strong></p>\r\n<p>Option B. Surgical resection: Correct. For patients with early stage HCC, preserved liver function, and no portal hypertension, surgical resection is the recommended treatment.</p>\r\n<p>Option C. Radiofrequency ablation: Incorrect. This is an option for patients who are not surgical candidates.</p>\r\n<p>Option D. Sorafenib: Incorrect. <strong>Sorafenib is used for advanced HCC with extrahepatic spread.</strong></p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}